|9 Months Ended|
Sep. 30, 2021
NOTE 7 — EQUITY
On June 18, 2020, the Company entered into a Purchase Agreement with Piper Sandler & Co. and Canaccord Genuity LLC, as representatives of the several underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell 3,125,000 shares of its common stock. Under the terms of the Purchase Agreement, the Company granted to the Underwriters an option, exercisable for a period of 26.6 million.days, to purchase up to an additional shares of the Company’s common stock, which the Underwriters exercised in full on . The Underwriters purchased the shares pursuant to the Purchase Agreement, including the shares subject to the option, at a price of $ per share. Proceeds to the Company, net of discounts, commissions, fees and expenses, were $
On November 16, 2020, the Company announced that its Board of Directors had authorized a stock repurchase program under which the Company may purchase up to $10.0 million of its outstanding common stock through December 31, 2021. As of September 30, 2021, the Company had purchased shares for an aggregate $3,499,358 pursuant to this program. Management does not intend to make any further purchases before the end of the year.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef